Collectively, these results support the epigenetic regulatory effects of SLIT2 promoter methylation on the expression of SLIT2-embedded ncRNAs SLIT2-IT1/miR-218 in CML. The gene discussed is HAUS3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.